UNRESECTABLE NUT CARCINOMA
Clinical trials for UNRESECTABLE NUT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE NUT CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE NUT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo tackles rare, aggressive cancer
Disease control Recruiting nowThis study tests a new drug, ZEN003694, combined with standard chemotherapy for people with a rare and aggressive cancer called NUT carcinoma. The goal is to find the safest dose and see if the combination shrinks tumors. About 36 adults with advanced or spreading NUT carcinoma w…
Matched conditions: UNRESECTABLE NUT CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests the safety and best dose of two drugs, ZEN003694 and abemaciclib, given together. It is for people with advanced breast cancer, NUT carcinoma, or other solid tumors that have spread or cannot be removed by surgery. The goal is to see if the combinatio…
Matched conditions: UNRESECTABLE NUT CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Immunotherapy drug cemiplimab takes on rare, incurable cancer
Disease control Recruiting nowThis phase 2 trial is testing whether the immunotherapy drug cemiplimab can help people with NUT carcinoma, a rare and aggressive cancer that has spread or cannot be removed by surgery. The study will enroll 15 participants and measure how long they live and whether their tumors …
Matched conditions: UNRESECTABLE NUT CARCINOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC